Other Reports

National Academies Press. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (2017). ISBN: 978-0-309-45304-2. DOI: 10.17226/24625

Curran HV, Freeman TP, Mokrysz C, Lewis DA, Morgan CJ, Parsons LH. Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci. 2016 May;17(5):293-306. doi: 10.1038/nrn.2016.28. Epub 2016 Apr 7.

AAA Foundation for Traffic Safety. An Evaluation of Data from Drivers Arrested for Driving Under the Influence in Relation to Per se Limits for Cannabis. May, 2016.

AAA Foundation for Traffic Safety. Prevalence of Marijuana Involvement in Fatal Crashes: Washington, 2010 - 2014. May, 2016.

Federation of State Medical Boards. Model Guidelines for the Recommendation of Marijuana in Patient Care. April, 2016.

World Health Organization (WHO). The health and social effects of nonmedical cannabis use. 2016.

Rogeberg O, Elvik R. The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction. 2016 Feb 16. doi: 10.1111/add.13347.

Piomelli D, Grant I. Medicinal Cannabis in California: an interview with Igor Grant, MD. Cannabis and Cannabinoid Research 1:1, 78–80, DOI: 10.1089/can.2016.29005.igr.

Jackson NJ, Isen JD, Khoddam R, Irons D, Tuvblad C, Iacono WG, McGue M, Raine A, Baker LA. Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies. Proc Natl Acad Sci USA. 2016 Feb 2;113(5):E500-8. doi: 10.1073/pnas.1516648113. Epub 2016 Jan 19.

Wong K & Clarke C. (2015, September). The Legalization of Marijuana in Colorado: The Impact. Rocky Mountain High Intensity Drug Trafficking Area.

Compton, R. P. & Berning, A. (2015, February). Drug and alcohol crash risk. (Traffic Safety Facts Research Note. DOT HS 812 117). Washington, DC: National Highway Traffic Safety Administration.

Weiland BJ, Thayer RE, Depue BE, Sabbineni A, Bryan AD, Hutchison KE. Daily marijuana use is not associated with brain morphometric measures in adolescents or adults. J Neurosci. 2015 Jan 28;35(4):1505-12. doi: 10.1523/JNEUROSCI.2946-14.2015.

American Academy of Pediatrics, Policy Statement. The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update. Pediatrics. 2015 Jan 26. pii: peds. 2014-4147.

American Academy of Pediatrics, Technical Report. The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update. Pediatrics. 2015 Jan 26. pii: peds. 2014-4146.

Power RA, Verweij KJ, Zuhair M, Montgomery GW, Henders AK, Heath AC, Madden PA, Medland SE, Wray NR, Martin NG. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry. 2014 Nov;19(11):1201-4. doi: 10.1038/mp.2014.51. Epub 2014 Jun 24.

Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014 Apr 29;82(17):1556-63.

Molina PE, Amedee AM, Lecapitaine NJ, Zabaleta J, Mohan M, Winsauer PJ, Vande Stouwe C, McGoey RR, Auten MW, Lamotte L, Chandra LC, Birke LL. Modulation of Gut-Specific Mechanisms by Chronic Δ9-Tetrahydrocannabinol Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis. AIDS Res Hum Retroviruses. 2014 Feb 7.

Porter BE, Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 2013 Dec;29(3):574-7. doi: 10.1016/j.yebeh.2013.08.037.

Sirven JI. Medical marijuana for epilepsy: Winds of change. Epilepsy Behav. 2013 Dec;29(3):435-6. doi: 10.1016/j.yebeh.2013.09.004.

Cooper ZD, Comer SD, Haney M. Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily Marijuana Smokers. Neuropsychopharmacology. 2013 Apr 22. doi: 10.1038/npp.2013.97.

Schier AR, Ribeiro NP, de Oliveira e Silva AC, Hallak JE, Crippa JA, Nardi AE, Zuardi AW. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug. Rev Bras Psiquiatr. 2012 Jun;34 Suppl 1:S104-10. English, Portuguese.

Abrams DA, Couey P, Shade SB, Kelly ME, Benowitz NL. Cannabinoid-Opioid Interaction in Chronic Pain. Clinical Pharmacology & Therapeutics (2011); 90 6, 844–851. doi:10.1038/clpt.2011.188.

California Medical Association. Cannabis and the Regulatory Void: Background Paper and Recommendations. (2011)

American Society of Addiction Medicine, President’s Action Committee on Medical Marijuana. The Role of the Physician in "Medical" Marijuana. Barthwell A., Baxter L., Cermak T., DuPont R., Kraus M., Levounis P. September 2010.

Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, Gamsa A, Bennett GJ, Collet JP. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 10.1503/cmaj.091414. August 2010.

Center for Medicinal Cannabis Research: Report to the California Legislature (2010)

American Medical Association, Report 3 of the Council on Science and Public Health, Use of Cannabis for Medicinal Purposes (2009)

American College of Physicians, Position Paper: Supporting Research into the Therapeutic Role of Marijuana (2008)

Action Report: Medical Board of California, July 2004. California Physicians & Medical Marijuana: A Statement by the Medical Board of California -- May 7, 2004

National Institute on Drug Abuse, Conference Summary, 2001: Workshop on Clinical Consequences of Marijuana

Institute of Medicine Report, 2000: Marijuana As Medicine?: The Science Beyond the Controversy

Institute of Medicine Report, 1999: Marijuana and Medicine: Assessing the Science Base

The United Kingdom Parliament, House of Lords, Select Committee on Science & Technology, Ninth Report, November 4,1998, Cannabis: The Scientific & Medical Evidence

National Institutes of Health, Expert Panel Report, 1997: Workshop on the Medical Utility of Marijuana

The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics (CCIC)
A Summary of Research Abstracts - updated monthly



Igor Grant, MD

American Psychological Association Plenary Address: Marijuana as Medicine: Can we see past the smoke?
Denver, CO (August 2016)




Barth Wilsey, MD

Marijuana and Cannabinoids: A Neuroscience Research Summit;
Bethesda, MD (March 2016)



THE PSYCHIATRIC AND NEUROCOGNITIVE EFFECTS OF CANNABIS
(PDF)

Igor Grant, MD, FRCP(C) American Association for the Advancement of Science Annual Meeting

McGill University Health Centre - Research Institute
(February 2015)



Copyright © 2017 CENTER FOR MEDICINAL CANNABIS RESEARCH. | University of California, San Diego
cmcr@ucsd.edu | HNRP |